BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 29, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q3 2023 results. Q3 2023 revenue of its flagship VINIA® product reached USD 3.24M which is well within the projected range and represents 113% growth c
2023-11-29 8:00 AM EST
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 19 and October 20, 2023. The Company has issued Notes in the aggregate principal amount of CA$ 11,786,489.90, in this first tranche of an announced financing of...
2023-10-30 8:00 AM EDT
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 10, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that VINIA®, its flagship nutraceutical product derived from red grape cells, has received its Canadian product license from Health Canada's Natural and Non-Prescription Health Products Directorate. This Product License authorizes BioHarvest Sciences to sell VINIA
2023-10-10 11:55 AM EDT
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 6, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that US sales of its flagship product VINIA® in the month of August have crossed the USD 1Million per month line. This significant milestone marks a new inflection point in BioHarvest's journey and offers further validation of its Botanical Synthesis technology platform. This milestone also demonstrates the power...
2023-09-06 8:00 AM EDT
BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 30, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q2 2023 results. Revenue of its flagship VINIA® product reached USD 2.75M, representing 228% growth compared to the same quarter of last year and 27% growth compared to Q1 2
2023-08-30 8:00 AM EDT
BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 24, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") announces that it is hosting the Q2 Performance Update Presentation on Wednesday, September 6, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by CEO Ilan Sobel. Mr. Sobel will discuss the Q2 financials announced this coming August 30th, and he will provide additional information regarding major VINIA...
2023-08-24 8:40 AM EDT
BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 18, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed its non-brokered private placement of convertible notes (the "Notes") previously announced on July 7, 2023. The Company has issued Notes in the aggregate principal amount of CA$4,642,075.50. The Company has paid finder's fees of $41,282.20 to a finder on a portion of the private...
2023-07-18 8:00 AM EDT
BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2023) - Dr. Brian Cornblatt, the Chief Medical Officer of BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHarvest" or "the company"), delivered a keynote address on the "HealthConf" stage at the Collision conference in Toronto on Thursday. Dr. Cornblatt opened up for the first time about his medical misdiagnosis for Multiple Sclerosis, as well as various cancer experiences by friends and family, which compelled him...
2023-06-30 8:27 AM EDT
BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has been invited to one of the largest and fastest-growing technology conferences in North America. Its Chief Medical Officer, Dr. Brian Cornblatt, will deliver the keynote speech on the "HealthConf" stage at Collision on Thursday, June 29th at 10:45 am EST. After his keynote address, Dr. Cornblatt will host the stage...
2023-06-27 8:00 AM EDT
BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it will be participating in the Jefferies Vitamins and Supplements Conference, June 27, in London, England. BioHarvest Sciences CEO Ilan Sobel will be attending this prestigious industry conference as an invited speaker, and he will be included in a panel titled "Growing Impact of Emerging and Disruptive Brands."...
2023-06-26 9:21 AM EDT
BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") has unveiled a plan to enter new consumption categories where VINIA will be incorporated to create unique and highly differentiated products for the Food & Beverage and the Nutraceuticals markets. VINIA's success in the first two years since its 2021 US launch is not only celebratory in terms of significant reve
2023-06-21 8:00 AM EDT
BioHarvest Sciences Adds Renowned Scientist to Scientific Advisory Board
Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that it has added Dr. John Paul SanGiovanni, world renowned nutritionist and Harvard-trained scientist, to its Medical and Scientific Advisory board. Dr. SanGiovanni will act as a liaison with the spheres of Academia, Industry, and Government, helping spread the promise and potential of Botanical Synthesis. His deep connections within Academic and research institutions will introduce...
2023-06-06 8:00 AM EDT
BioHarvest Reports Q1 2023 Results Demonstrating Strong Year Over Year Growth
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 31, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it has released Q1 2023 results. Revenue of its flagship VINIA® product reach
2023-05-31 7:30 AM EDT
BioHarvest Adds over 25,000 US Customers in Last 365 Days and Congratulates NFL "Team VINIA" Prospects on Draft Day Success
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 4, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) has surpassed 2,000 verified online reviews for its flagship product, VINIA, following the launch of the first major 2023 marketing campaign, "Real Stories," focusing on the red grape-based supplement's impact on customers' lives. "Our online reviews do more than give new customers the confidence to try VINIA," said Dr. Brian Cornblatt, Chief Medical Officer. "The
2023-05-04 8:00 AM EDT
BioHarvest Sciences Named Honorable Mention in Wellness Category of Fast Company's 2023 World Changing Ideas Awards
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 3, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards. This annual Fast Company award celebrates “the sustainable designs, innovative products, bold social initiatives, and other creative...
2023-05-03 8:00 AM EDT
BioHarvest Sciences Contributing VINIA to NFL Training Camp Preparation
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "company") has announced that its VINIA partnership with House of Athlete trainer Yo Murphy has resulted in several of his high-profile players entering the NFL draft as members of "Team VINIA." The red grape-based supplement has also been selected by multiple
2023-04-27 8:00 AM EDT
BioHarvest Sciences to Host Virtual Shareholder Presentation May 4, 2pm ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or the "Company") announces that it is hosting a Shareholder Presentation on Thursday May 4, 2023, at 11am PST | 2 pm EST. The interactive session will be hosted by CEO Ilan Sobel, who will be joined by Chief Medical Officer Dr. Brian Cornblatt. Ilan Sobel will provide updates on current BioHarvest marketing initiatives, and Dr. Brian Cornblatt will...
2023-04-26 8:00 AM EDT
BioHarvest Sciences Hires Dr. Ilana Belzer as Chief Operating Officer
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 19, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") has hired, effective today, Dr. Ilana Belzer, Ph.D., as its Chief Operating Officer (COO), reporting to CEO Ilan Sobel, marking a significant milestone in the Company's commitment to driving continued growth and a relentless focus on achieving profitability in the near term. Dr. Belzer brings extensive leadership experience and technical...
2023-04-19 7:00 AM EDT
BioHarvest Sciences Announces Major Media Campaign to Focus on VINIA Real Stories
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 4, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (the Company) is announcing that its first major 2023 product marketing campaign has launched, titled "Real Stories". This campaign focuses on actual VINIA® users and their experiences, and it will include aggressive digital and social media marketing to support television content, which includes advertising content on major television networks, including Fox News, Hulu and...
2023-04-04 7:09 AM EDT
BioHarvest Sciences Announces a Private Placement of up to CAD $8M of Convertible Notes to Grow Core Business
Rehovot, Israel--(Newsfile Corp. - February 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") announced today a private placement of up to CAD $8 Million of two year convertible notes (the "Notes). The funds raised will predominantly support the Company's growth in its polyphenols/antioxidan
2023-02-21 3:06 PM EST